(Q37101325)

18 August 2017

1 reference

title

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy (English)

1 reference

18 August 2017

1 reference

1

Karl-Johan Malmberg

1 reference

18 August 2017

6

Niklas K Björkström

1 reference

18 August 2017

Yenan T Bryceson

2

1 reference

18 August 2017

Mattias Carlsten

3

1 reference

18 August 2017

Sandra Andersson

4

1 reference

18 August 2017

Andreas Björklund

5

1 reference

18 August 2017

Bettina C Baumann

7

1 reference

18 August 2017

Cyril Fauriat

8

1 reference

18 August 2017

Evren Alici

9

1 reference

18 August 2017

M Sirac Dilber

10

1 reference

18 August 2017

Hans-Gustaf Ljunggren

11

1 reference

18 August 2017

publication date

4 March 2008

1 reference

Cancer Immunology, Immunotherapy

18 August 2017

published in

1 reference

18 August 2017

volume

57

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

1541-1552

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-008-0492-7

18 August 2017

exact match

0 references

cites work

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

IL-21 induces the functional maturation of murine NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0492-7

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1084/JEM.162.6.1745

Identifiers

DOI

10.1007/S00262-008-0492-7

1 reference

18 August 2017

1 reference